Theratechnologies Inc (TSE:TH)’s share price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $5.38 and traded as low as $5.47. Theratechnologies shares last traded at $5.66, with a volume of 35,735 shares.
A number of brokerages recently issued reports on TH. Royal Bank of Canada decreased their price target on shares of Theratechnologies from C$10.00 to C$8.00 in a research note on Wednesday, July 3rd. National Bank Financial decreased their price target on shares of Theratechnologies from C$11.25 to C$8.25 and set a “sector perform” rating for the company in a research note on Friday, July 12th. Finally, Mackie decreased their price target on shares of Theratechnologies from C$8.15 to C$7.00 and set a “hold” rating for the company in a research note on Friday, July 12th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of C$9.56.
The business’s 50 day moving average is C$5.38 and its 200-day moving average is C$6.61. The company has a debt-to-equity ratio of 159.35, a current ratio of 2.69 and a quick ratio of 2.09. The company has a market cap of $426.32 million and a PE ratio of -90.32.
Theratechnologies (TSE:TH) last issued its quarterly earnings results on Thursday, July 11th. The company reported C($0.06) earnings per share (EPS) for the quarter. The company had revenue of C$20.92 million for the quarter, compared to the consensus estimate of C$26.00 million. As a group, sell-side analysts predict that Theratechnologies Inc will post 0.17 EPS for the current fiscal year.
A hedge fund recently bought a new stake in Theratechnologies stock. LLBH Private Wealth Management LLC acquired a new position in shares of Theratechnologies Inc (TSE:TH) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 182,631 shares of the company’s stock, valued at approximately $1,735,000. Theratechnologies makes up approximately 0.6% of LLBH Private Wealth Management LLC’s investment portfolio, making the stock its 28th biggest position. LLBH Private Wealth Management LLC owned approximately 0.24% of Theratechnologies as of its most recent filing with the Securities & Exchange Commission.
About Theratechnologies (TSE:TH)
Theratechnologies Inc, a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States.
Recommended Story: What are trading strategies for the 52-week high/low?
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.